CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Long-Term Clinical Outcomes of Korean Patient With Crohn's Disease Following Early Use of Infliximab
Nam Hee Kim, Yoon Suk Jung, Chang Mo Moon, Shin Yeong Lee, Eun Ran Kim, Young Ho Kim, Chang Kyun Lee, Suck Ho Lee, Jae Hak Kim, Kyu Chan Huh, Soon Man Yoon, Hyun Joo Song, Sun-Jin Boo, Hyun Joo Jang, You Sun Kim, Kang-Moon Lee, Jeong Eun Shin, Dong Il Park
Intest Res. 2014;12(4):281-286.   Published online October 27, 2014
DOI: https://doi.org/10.5217/ir.2014.12.4.281

Excel Download

Long-Term Clinical Outcomes of Korean Patient With Crohn's Disease Following Early Use of Infliximab
Intestinal Research. 2014;12(4):281   Crossref logo
Link1

Long-term Efficacy and Predictors of Response to Infliximab in Korean Patients with Crohn's Disease
The Korean Journal of Gastroenterology. 2013;61(5):241   Crossref logo
Link1 Link2 Link3

P405 Comparison of long-term outcomes of infliximab vs. adalimumab in 1488 biologic-naive Korean patients with Crohn’s disease
Journal of Crohn's and Colitis. 2020;14(Supplement_1):S374-S374   Crossref logo
Link1 Link2

Infliximab in Crohn's disease: early and long-term treatment
Digestive and Liver Disease. 2008;40:S271-S279   Crossref logo
Link1 Link2

M1152 Long-Term Outcomes in Infliximab Recipients Are Independent of Concomitant Immunomodulator Use in Patients with Crohn's Disease
Gastroenterology. 2008;134(4):A-349   Crossref logo
Link1 Link2

Infliximab reduces resource use in Crohn's disease
PharmacoEconomics & Outcomes News. 2002;381(1):6-6   Crossref logo
Link1 Link2 Link3

Infliximab reduces resource use and costs in Crohn's disease
PharmacoEconomics & Outcomes News. 2013;681(1):3-3   Crossref logo
Link1 Link2 Link3

Tu1150 Association of Serum Infliximab and Antibodies to Infliximab to Long-Term Clinical Outcome and Mucosal Healing in Crohn's Disease
Gastroenterology. 2013;144(5):S-775   Crossref logo
Link1 Link2

Long-term clinical outcomes in patients with refractory uveitis associated with Behçet's disease treated with infliximab
Acta Ophthalmologica. 2013;91:0-0   Crossref logo
Link1 Link2

Sa1274 Prior Use of Infliximab As a Predictor of Long-Term Outcomes of Treatment With Certolizumab Pegol for Active Crohn's Disease: Analyses From the Precise 3 7-Year Study
Gastroenterology. 2014;146(5):S-249   Crossref logo
Link1 Link2